Guangzhou Han

1.5k total citations
15 papers, 812 citations indexed

About

Guangzhou Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Guangzhou Han has authored 15 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Guangzhou Han's work include Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Prostate Cancer Treatment and Research (5 papers). Guangzhou Han is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Prostate Cancer Treatment and Research (5 papers). Guangzhou Han collaborates with scholars based in United States, Australia and Italy. Guangzhou Han's co-authors include Jonathan M. Harris, Wayne D. Tilley, Grant Buchanan, Norman M. Greenberg, Barbara A. Foster, Donald L. Trump, Xiaoqing Yu, Candace S. Johnson, Weidong Yu and Ivy Chung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Guangzhou Han

14 papers receiving 798 citations

Peers

Guangzhou Han
Natasja F. Dits Netherlands
Dennis Faith United States
Paola Collecchi Italy
Robin L. Goode United States
Addie Dvir Israel
Cai Bowen United States
Yuanjie Niu China
Masahiko Ikeda Japan
Lindy Goddard United Kingdom
Y.C. Wong Hong Kong
Natasja F. Dits Netherlands
Guangzhou Han
Citations per year, relative to Guangzhou Han Guangzhou Han (= 1×) peers Natasja F. Dits

Countries citing papers authored by Guangzhou Han

Since Specialization
Citations

This map shows the geographic impact of Guangzhou Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangzhou Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangzhou Han more than expected).

Fields of papers citing papers by Guangzhou Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangzhou Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangzhou Han. The network helps show where Guangzhou Han may publish in the future.

Co-authorship network of co-authors of Guangzhou Han

This figure shows the co-authorship network connecting the top 25 collaborators of Guangzhou Han. A scholar is included among the top collaborators of Guangzhou Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangzhou Han. Guangzhou Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lin, Fanching, Takeru Ehara, Steven V. Horton, et al.. (2024). Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma. Journal of Nuclear Medicine. 65(4). 586–592. 29 indexed citations
2.
Lin, Fanching, Takeru Ehara, Steven V. Horton, et al.. (2024). Novel GPC3-targeting radiopharmaceutical therapy for hepatocellular carcinoma.. Journal of Clinical Oncology. 42(3_suppl). 525–525. 3 indexed citations
3.
Lin, Fanching, et al.. (2024). Abstract 6020: GPC3-targeted radiopharmaceutical therapy for neuroendocrine prostate cancer. Cancer Research. 84(6_Supplement). 6020–6020. 1 indexed citations
4.
Han, Guangzhou, Eunmi Hwang, Fanching Lin, et al.. (2023). Abstract 5042: Anti-tumor activity of RYZ101 (Ac-225 DOTATATE) in somatostatin receptor-expressing preclinical models of small-cell lung cancer. Cancer Research. 83(7_Supplement). 5042–5042. 1 indexed citations
5.
Li, Gary, Fanching Lin, Takeru Ehara, et al.. (2023). Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma.. Journal of Clinical Oncology. 41(16_suppl). e16131–e16131. 1 indexed citations
6.
Richardson, Samantha J., Takeru Ehara, M. Mason Guest, et al.. (2023). Novel peptide binder for EphA2-targeted radiopharmaceutical therapy for multiple solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15113–e15113.
7.
Han, Guangzhou, et al.. (2023). RYZ101 (Ac-225 DOTATATE) Opportunity beyond Gastroenteropancreatic Neuroendocrine Tumors: Preclinical Efficacy in Small-Cell Lung Cancer. Molecular Cancer Therapeutics. 22(12). 1434–1443. 13 indexed citations
8.
9.
10.
Eswaraka, Jeetendra, Anand Giddabasappa, Guangzhou Han, et al.. (2014). Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. BMC Cancer. 14(1). 742–742. 15 indexed citations
11.
Qiu, Ming, Qinghai Peng, Christopher L. Carroll, et al.. (2012). Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Letters. 328(2). 261–270. 109 indexed citations
12.
Chung, Ivy, Guangzhou Han, Mukund Seshadri, et al.. (2009). Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo. Cancer Research. 69(3). 967–975. 142 indexed citations
13.
Han, Guangzhou, Grant Buchanan, Michael Ittmann, et al.. (2005). Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proceedings of the National Academy of Sciences. 102(4). 1151–1156. 144 indexed citations
14.
Han, Guangzhou, Barbara A. Foster, Sandeep Mistry, et al.. (2001). Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer. Journal of Biological Chemistry. 276(14). 11204–11213. 99 indexed citations
15.
Buchanan, Grant, Miao Yang, Jonathan M. Harris, et al.. (2001). Mutations at the Boundary of the Hinge and Ligand Binding Domain of the Androgen Receptor Confer Increased Transactivation Function. Molecular Endocrinology. 15(1). 46–56. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natasja F. Dits Breakdown of academic impact, for papers by Dennis Faith Breakdown of academic impact, for papers by Paola Collecchi Breakdown of academic impact, for papers by Robin L. Goode Breakdown of academic impact, for papers by Addie Dvir Breakdown of academic impact, for papers by Cai Bowen Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Masahiko Ikeda Breakdown of academic impact, for papers by Lindy Goddard Breakdown of academic impact, for papers by Y.C. Wong
Rankless by CCL
2026